AZ and Novoheart create a 3D heart model

AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its kind. The ‘heart-in-a-jar’, Novoheart’s proprietary 3D human ventricular cardiac organoid chamber (hvCOC) technology, will be made from human stem cells and will replicate the key characteristics of heart failure. This will include preserved ejection fraction

Continue Reading

New Disease Compounds Research Library Launched by the Medical Research Council

The Medical Research Council (MRC) has teamed up with six pharmaceutical companies to create a disease compounds library for academic researchers around the world. The library is the latest product of the MRC’s Industry Asset Sharing Initiative, which comprises of 47 deprioritised compounds contributed by AstraZeneca, GlaxoSmithKline, Janssen, Pfizer, Takeda and UCB. Both pre-clinical and

Continue Reading